Cargando…

MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease

BACKGROUND: Lung inflammation in COPD is poorly controlled by inhaled corticosteroids (ICS). Strategies to improve ICS efficacy or the search of biomarkers who may select those patients candidates to receive ICS in COPD are needed. Recent data indicate that MUC1 cytoplasmic tail (CT) membrane mucin...

Descripción completa

Detalles Bibliográficos
Autores principales: Milara, Javier, Díaz-Platas, Lucía, Contreras, Sonia, Ribera, Pilar, Roger, Inés, Ballester, Beatriz, Montero, Paula, Cogolludo, Ángel, Morcillo, Esteban, Cortijo, Julio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247701/
https://www.ncbi.nlm.nih.gov/pubmed/30458870
http://dx.doi.org/10.1186/s12931-018-0927-4
_version_ 1783372535607328768
author Milara, Javier
Díaz-Platas, Lucía
Contreras, Sonia
Ribera, Pilar
Roger, Inés
Ballester, Beatriz
Montero, Paula
Cogolludo, Ángel
Morcillo, Esteban
Cortijo, Julio
author_facet Milara, Javier
Díaz-Platas, Lucía
Contreras, Sonia
Ribera, Pilar
Roger, Inés
Ballester, Beatriz
Montero, Paula
Cogolludo, Ángel
Morcillo, Esteban
Cortijo, Julio
author_sort Milara, Javier
collection PubMed
description BACKGROUND: Lung inflammation in COPD is poorly controlled by inhaled corticosteroids (ICS). Strategies to improve ICS efficacy or the search of biomarkers who may select those patients candidates to receive ICS in COPD are needed. Recent data indicate that MUC1 cytoplasmic tail (CT) membrane mucin can mediate corticosteroid efficacy in chronic rhinosinusitis. The objective of this work was to analyze the previously unexplored role of MUC1 on corticosteroid efficacy in COPD in vitro and in vivo models. METHODS: MUC1-CT expression was measured by real time PCR, western blot, immunohistochemistry and immunofluorescence. The inflammatory mediators IL-8, MMP9, GM-CSF and MIP3α were measured by ELISA. The effect of MUC1 on inflammation and corticosteroid anti-inflammatory effects was measured using cell siRNA in vitro and Muc1-KO in vivo animal models. RESULTS: MUC1-CT expression was downregulated in lung tissue, bronchial epithelial cells and lung neutrophils from smokers (n = 11) and COPD (n = 11) patients compared with healthy subjects (n = 10). MUC1 was correlated with FEV1% (ρ = 0.7479; p < 0.0001) in smokers and COPD patients. Cigarette smoke extract (CSE) decreased the expression of MUC1 and induced corticosteroid resistance in human primary bronchial epithelial cells and human neutrophils. MUC1 Gene silencing using siRNA-MUC1 impaired the anti-inflammatory effects of dexamethasone and reduced glucocorticoid response element activation. Dexamethasone promoted glucocorticoid receptor alpha (GRα) and MUC1-CT nuclear translocation and co-localization that was inhibited by CSE. Lung function decline and inflammation induced by lipopolysaccharide and cigarette smoke in Muc1 KO mice was resistant to dexamethasone. CONCLUSIONS: These results confirm a role for MUC1-CT mediating corticosteroid efficacy in COPD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12931-018-0927-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6247701
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62477012018-11-26 MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease Milara, Javier Díaz-Platas, Lucía Contreras, Sonia Ribera, Pilar Roger, Inés Ballester, Beatriz Montero, Paula Cogolludo, Ángel Morcillo, Esteban Cortijo, Julio Respir Res Research BACKGROUND: Lung inflammation in COPD is poorly controlled by inhaled corticosteroids (ICS). Strategies to improve ICS efficacy or the search of biomarkers who may select those patients candidates to receive ICS in COPD are needed. Recent data indicate that MUC1 cytoplasmic tail (CT) membrane mucin can mediate corticosteroid efficacy in chronic rhinosinusitis. The objective of this work was to analyze the previously unexplored role of MUC1 on corticosteroid efficacy in COPD in vitro and in vivo models. METHODS: MUC1-CT expression was measured by real time PCR, western blot, immunohistochemistry and immunofluorescence. The inflammatory mediators IL-8, MMP9, GM-CSF and MIP3α were measured by ELISA. The effect of MUC1 on inflammation and corticosteroid anti-inflammatory effects was measured using cell siRNA in vitro and Muc1-KO in vivo animal models. RESULTS: MUC1-CT expression was downregulated in lung tissue, bronchial epithelial cells and lung neutrophils from smokers (n = 11) and COPD (n = 11) patients compared with healthy subjects (n = 10). MUC1 was correlated with FEV1% (ρ = 0.7479; p < 0.0001) in smokers and COPD patients. Cigarette smoke extract (CSE) decreased the expression of MUC1 and induced corticosteroid resistance in human primary bronchial epithelial cells and human neutrophils. MUC1 Gene silencing using siRNA-MUC1 impaired the anti-inflammatory effects of dexamethasone and reduced glucocorticoid response element activation. Dexamethasone promoted glucocorticoid receptor alpha (GRα) and MUC1-CT nuclear translocation and co-localization that was inhibited by CSE. Lung function decline and inflammation induced by lipopolysaccharide and cigarette smoke in Muc1 KO mice was resistant to dexamethasone. CONCLUSIONS: These results confirm a role for MUC1-CT mediating corticosteroid efficacy in COPD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12931-018-0927-4) contains supplementary material, which is available to authorized users. BioMed Central 2018-11-20 2018 /pmc/articles/PMC6247701/ /pubmed/30458870 http://dx.doi.org/10.1186/s12931-018-0927-4 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Milara, Javier
Díaz-Platas, Lucía
Contreras, Sonia
Ribera, Pilar
Roger, Inés
Ballester, Beatriz
Montero, Paula
Cogolludo, Ángel
Morcillo, Esteban
Cortijo, Julio
MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease
title MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease
title_full MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease
title_fullStr MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease
title_full_unstemmed MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease
title_short MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease
title_sort muc1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247701/
https://www.ncbi.nlm.nih.gov/pubmed/30458870
http://dx.doi.org/10.1186/s12931-018-0927-4
work_keys_str_mv AT milarajavier muc1deficiencymediatescorticosteroidresistanceinchronicobstructivepulmonarydisease
AT diazplataslucia muc1deficiencymediatescorticosteroidresistanceinchronicobstructivepulmonarydisease
AT contrerassonia muc1deficiencymediatescorticosteroidresistanceinchronicobstructivepulmonarydisease
AT riberapilar muc1deficiencymediatescorticosteroidresistanceinchronicobstructivepulmonarydisease
AT rogerines muc1deficiencymediatescorticosteroidresistanceinchronicobstructivepulmonarydisease
AT ballesterbeatriz muc1deficiencymediatescorticosteroidresistanceinchronicobstructivepulmonarydisease
AT monteropaula muc1deficiencymediatescorticosteroidresistanceinchronicobstructivepulmonarydisease
AT cogolludoangel muc1deficiencymediatescorticosteroidresistanceinchronicobstructivepulmonarydisease
AT morcilloesteban muc1deficiencymediatescorticosteroidresistanceinchronicobstructivepulmonarydisease
AT cortijojulio muc1deficiencymediatescorticosteroidresistanceinchronicobstructivepulmonarydisease